Menu Back toPresenters

DIA Medical Affairs forum 2021 in Japan

All prices are exclusive of 10% Japanese consumption tax


  • Sonoko  Misawa, MD, PhD

    Sonoko Misawa, MD, PhD

    • Associate Professor
    • Chiba University, Japan

  • Tadashi  Urashima, PhD

    Tadashi Urashima, PhD

    • Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    • GlaxoSmithKline K.K., Japan

    Dr. Tadashi Urashima is MSL manager at GlaxoSmithKline K.K. Dr. Urashima is leading MSL activity in Specialty area as a MSL manager. In addition to the position, Dr. Urashima is leading digital engagement for medical activities. Dr. Urashima has extensive experiences such as clinical development, medical excellence, change management etc 20 years at GSK. Dr. Urashima has a certification of LSS MBB and contributed to various business improvement. Dr. Urashima holds a PhD for regenerative medicine in Tottori University. Dr. Urashima has been certified as Professional Coach in Foundation of Global Life Learning Center. Also. Dr. Urashima is DIA MA community member and played sub chair at 1st DIA MA Forum which took place this September.

  • Shinichi  Nishiuma, MD

    Shinichi Nishiuma, MD

    • Head of Oncology Medical Science, Japan medical
    • BMS, Japan

    Dr. Shinichi Nishiuma is Head of Oncology Medical Science, Japan medical at Bristol Myers Squibb In this position, Dr. Nishiuma is responsible for leading and overseeing all medical activities across Celgene Japan. Dr. Nishiuma has over 15 years' experience in pharmaceutical industries, including clinical development, drug safety, RWE/epidemiology and medical affairs. Dr. Nishiuma holds M.D. from Kobe University and worked at Kobe city general hospital as a gastroenterologist prior to joining the industry. Dr. Nishiuma also serves as a board member and vice-president at Japanese association of pharmaceutical medicine.

  • Mitsutoshi  Toda, MBA

    Mitsutoshi Toda, MBA

    • Group Manager, CRM Medical Franchise Dept. Japan Medical Division
    • Novartis Pharma K.K., Japan

  • Shuji  Uno, PhD

    Shuji Uno, PhD

    • Medical Lead, Hematology, Japan Medical
    • Bristol-Myers Squibb K.K., Japan

    Shuji Uno has served as Medical Lead at Medical Affairs department in BMS K.K. since July 2020. Shuji is responsible for Medical Plan development via UMNs identification and any activities of Evidence Generation in hematology area, such as company-sponsored studies, investigator-sponsored studies, and publication. He has over 8 years of experineces in Medical Affairs department including field work experiences as MSL in pharmaceutical industry. He holds a Ph.D. in life science from University of Tokyo.

  • Hajime  Saijo

    Hajime Saijo

    • Sr. Vice President, Managing Director
    • SH DIA Japan, Japan

    Hajime “Jim” Saijo, PhD, MBA, is the Sr. VP, managing director of DIA Japan. He previously established and lead the Academia Clinical Research Division, CMIC K.K., as Corporate Officer managing clinical research and investigator sponsored clinical trials. Dr. Saijo’s experience also includes serving as Director of R&D for Alcon Japan; Director of R&D and Representative Director for start-up operations of Ferring Pharmaceuticals Co. Ltd.; and as VP of Medical, Clinical and Regulatory Affairs for Japan & APEC for OvaScience. Dr. Saijo earned his PhD in Medical Science from Tokyo Medical and Dental University Graduate School of Medicine and Dentistry, and his MBA in Business Administration from Temple University Business School, Japan Campus.

  • Jun  Fukuyoshi, MBA

    Jun Fukuyoshi, MBA

    • CEO & Founder
    • Cancerscan Inc., Japan

  • Kiyotaka  Ishige

    Kiyotaka Ishige

    • Partner
    • PwC Consulting LLC, Japan

  • Hideki  Ninomiya, MD

    Hideki Ninomiya, MD

    • CEO
    • Datack Inc, Japan

    Hideki Ninomiya graduated from the University of Tokyo's School of Medicine. After working as a neurosurgeon, he entered the world of data science. He engaged in medical information and telemedicine at Medley Inc. Afterwards, he started his own company, Datack Inc.

  • Ryo  Ishinishi

    Ryo Ishinishi

    • Associate Manager, Digital Compliance Group, Business Strategy & Compliance Dept
    • Chugai Pharmaceutical Co., Ltd., Japan

  • Koji  Kawakami, MD, PhD

    Koji Kawakami, MD, PhD

    • Professor and Chair, Department of Pharmacoepidemiology
    • Graduate School of Medicine and Public Health, Kyoto University, Japan

    Koji Kawakami, MD, PhD is Professor and Chair, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University. After the residency training in head and neck surgery and otorhinolaryngology, Dr. Kawakami served as postdoc and later promoted to clinical trial (IND) reviewer at CBER of U.S. FDA from 1999-2004. In 2006, Dr. Kawakami moved to Kyoto University to serve his current position, where he conducts various research programs focusing on clinical epidemiology and pharmaco epidemiology, and cost effectiveness researches utilizing various medical and healthcare databases. He has published more than 140 original articles in peer-reviewed global scientific journals as of August 2016.

  • Atsushi  Mizuno, MD, PhD, MBA

    Atsushi Mizuno, MD, PhD, MBA

    • Department of Cardiology, QI center
    • St. Luke's International Hospital, Japan

  • Takeshi  Ishido

    Takeshi Ishido

    • Sr Manager, Medical Contetn, Medical Excellence
    • Bristol-Myers Squibb.K.K. , Japan

  • Takashi  Moriya, PhD, MBA

    Takashi Moriya, PhD, MBA

    • Product Owner (Senior Manager) - Healthcare
    • Woven Alpha, Inc. (Woven Planet Holdings, Inc. group company), Japan

    Takashi is a director of Data Sciences, newly established department, in Janssen Japan R&D Division since June, 2019. His professional experiences range from Discovery Research, Clinical Development to Medical Affairs in Liver, Diabetes, Cardiovascular/Metabolic, Infection, Hematology and others. He also has extensive experiences in Clinical Statistics and IT system/database/sofware development during his 19-years of pharma industry career (Pfizer, RaQualia, Eli Lilly, Gilead and Chugai/Roche) after graduating from Duke University in Chemistry and Toxicology (2000). He holds a Ph.D. degree (2012) in NASH research from Nagoya University's Medical School and an Executive MBA degree (2018) from Keio Business School while he worked full-time.

  • Yoshiyuki  Sugimoto

    Yoshiyuki Sugimoto

    • Medical Manager
    • Sanofi K.K., Japan

    Dr. Yoshiyuki Sugimoto is the Scientifica Advisor in Medical Affairs at AbbVie Japan. Dr. Sugimoto graduated from Faculty of Pharmaceutical Sciences, the University of Tokyo in 1998 and completed Master's course at Graduate School of Pharmaceutical Science, the University of Tokyo in 2000. Dr. Sugimoto Joined Kyowa Hakko Kogyo Co., Ltd. (current Kyowa Kirin Co., Ltd.) in 2000, and moved to AbbVie Japan in 2016. Dr. Sugimoto has over 20 years’ experience in Pharmaceutical industry including Research, Development and Medical Affairs. Currently Dr. Sugimoto works for Rheumatology Medical Affairs Team and plays a leading role in the strategy of rheumatology field. Dr. Sugimoto obtained PhD degree from Waseda University in 2014.

  • Tetsuya  Watanabe, RPh

    Tetsuya Watanabe, RPh

    • Senior Medical Director, Medical Affairs
    • Astellas Pharma Inc., Japan